PapersPMID:39599686
Carnosine Supplementation Has No Effect on Inflammatory Markers in Adults with Prediabetes and Type 2 Diabetes: A Randomised Controlled Trial.
- findings
- 3
- compound
- 1
- endpoints
- 3
- Study, every finding
- RCT · 41 participants · 3 months
- Dose studied, every finding
- 2 g/day carnosine for 14 weeks versus matching placebo
- Population, every finding
- Adults with prediabetes or well-controlled type 2 diabetes (diet or metformin only), per-protocol analysis of 19 carnosine and 22 placebo
No finding here moved its endpoint.
What did not
How to read these marks →“There were no significant differences in changes in MCP-1, CRP, IL-6, IL-10, and TNF-α levels between the carnosine and placebo groups.”
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Adults aged 18-70 years with prediabetes or well-controlled type 2 diabetes treated with diet or metformin; secondary analysis
- Participants
- 49
- Comparator
- placebo
- Duration
- 98 days
- Endpoints measured
- 12